Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pediatr.

Sec. Pediatric Urology

Volume 13 - 2025 | doi: 10.3389/fped.2025.1584280

Burden of Urogenital Congenital Anomalies: Findings from the Global Burden of Disease Study 2021

Provisionally accepted
Yi Wei  YueYi Wei YueQian  ZhangQian Zhang*Ji  LiJi LiLei  WangLei WangLihua  GuoLihua GuoQuan  SunQuan Sun
  • Department of Pediatric Surgery,The First Affiliated Hospital of Zhengzhou University, Zheng Zhou, China

The final, formatted version of the article will be published soon.

Background: Urogenital congenital anomalies (UCAs) are among the most common organ system abnormalities in the neonate. This study employs Global Burden of Disease, Injury, and Risk Factor Study 2021 (GBD 2021) to systematically quantify the global epidemiological burden of UCAs from 1990 to 2021, examining geographic variations and temporal trends. Materials and Methods: Data were extracted from the GBD 2021. We focused on UCAs-related metrics: prevalence, incidence, deaths, and disability-adjusted life years (DALYs) across 204 countries and territories, grouped into 5 or 21 GBD regions by the socio-demographic index (SDI). Data analysis encompassed relative change calculations, as well as annual percentage change (APC) and average annual percentage change (AAPC), both of which are based on joinpoint regression analysis. The study additionally employed decomposition analysis, frontier analysis and cross-country health inequality analysis. Analyses utilized R version 4.3.1. Results: From 1990 to 2021, the global prevalence of UCAs cases surged by 21%, exceeding 6.34 million, accompanied by an increase in age-standardized rates. Incidence, mortality, and DALYs experienced declines in both absolute figures and age-standardized rates. Gender-specific trends from 1990 to 2021 revealed that females dominated in prevalence, while males had higher mortality and DALYs burden. Regionally, Southern Sub-Saharan Africa exhibited the highest prevalence, while Oceania and East Asia showed significant increases and decreases, respectively. Decomposition analysis of change in prevalence indicated that, globally, population contributed the most to changes in prevalence, followed by aging and epidemiological change. Frontier analysis of 204 countries and regions linked higher SDIs to lower UCAs prevalence. However, unexpected deviations were observed in some high SDI countries, such as Singapore and South Korea. Health inequality analysis revealed that the health inequality in prevalence between high-income and low-income countries decreased in 2021, although the burden became more concentrated in low-income countries. Conclusion: Our analysis highlights the intricate relationship between socio-demographic factors and UCAs trends, underscoring the urgent need for targeted and context-specific healthcare interventions. While significant advancements have been made, sustained vigilance and ongoing research remain critical to achieving effective global management of UCAs.

Keywords: Annual percentage change, average annual percentage change, Frontier analysis, Urogenital congenital anomalies, Decomposition analysis, cross-country health inequality analysis

Received: 28 Apr 2025; Accepted: 15 Sep 2025.

Copyright: © 2025 Yue, Zhang, Li, Wang, Guo and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Qian Zhang, shanyan@zzu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.